Insulet (PODD) Change in Receivables (2010 - 2025)
Insulet (PODD) posted Change in Receivables of $209.8 million for Q4 2025, up 13012.5% on a QoQ basis from $1.6 million in Q3 2025, and up 832.44% year-over-year from $22.5 million in Q4 2024.
Insulet (PODD) Change in Receivables (2010 - 2025) Analysis & Trends
Insulet's Change in Receivables history runs 14 years deep, the most recent figure standing at $209.8 million for Q4 2025.
- Quarterly Change in Receivables rose 832.44% year-over-year to $209.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $247.0 million (up 339.5% YoY) and the FY2025 annual result came in at $253.2 million, up 1398.22% from the prior year.
- Change in Receivables was $209.8 million for Q4 2025 at Insulet, up from $1.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $209.8 million in Q4 2025 and bottomed at -$33.1 million in Q1 2024.
- A 5-year average of $21.4 million and a median of $7.0 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables plunged 430.56% — and 2025, when it surged 832.44%.
- Insulet's Change in Receivables stood at $19.6 million in 2021, then slumped by 178.57% to -$15.4 million in 2022, then surged by 646.75% to $84.2 million in 2023, then plunged by 73.28% to $22.5 million in 2024, then jumped by 832.44% to $209.8 million in 2025.
- Business Quant data shows PODD's Change in Receivables at $209.8 million in Q4 2025, $1.6 million in Q3 2025, and $35.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | - |
| 10 | Insulet | 11.56 Bn | 11.07 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 209.80 Mn |
| Dec 31, 2025 | 209.80 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | -16.80 Mn |
| Sep 30, 2024 | -16.80 Mn |
| Jun 30, 2024 | 44.30 Mn |
| Jun 30, 2024 | 44.30 Mn |
| Mar 31, 2024 | -33.10 Mn |
| Mar 31, 2024 | -33.10 Mn |
| Dec 31, 2023 | 84.20 Mn |
| Dec 31, 2023 | 84.20 Mn |
| Sep 30, 2023 | -11.90 Mn |
| Sep 30, 2023 | -11.90 Mn |